Verona Pharma plc - American Depositary Share (VRNA) Social Stream



Verona Pharma plc - American Depositary Share (VRNA): $12.00

0.60 (-4.76%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

Add VRNA to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#263 of 358

in industry

VERONA PHARMA PLC (VRNA) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering VRNA.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-10 5 $25 $17 $20.6 $18.86 9.23%
2022-01-24 4 $25 $17 $21.6 $18.86 14.53%
2022-05-23 5 $25 $17 $21.6 $18.86 14.53%
2022-07-27 5 $25 $17 $20.2 $18.86 7.1%
2022-08-09 5 $30 $20 $24.2 $18.86 28.31%
2022-08-26 6 $31 $20 $25.333 $18.86 34.32%
2022-08-29 6 $31 $20 $26.166 $18.86 38.74%
2022-11-06 6 $31 $20 $26.833 $18.86 42.27%
2022-12-18 5 $31 $20 $26.8 $18.86 42.1%
2022-12-20 6 $31 $20 $26.8 $18.86 42.1%
2023-02-07 6 $33 $26 $30 $18.86 59.07%
2023-03-06 5 $35 $26 $30.333 $18.86 60.83%
2023-03-13 6 $35 $26 $30.333 $18.86 60.83%
2023-05-10 6 $35 $28 $31.142 $18.86 65.12%
2023-06-02 6 $38 $28 $31.857 $18.86 68.91%
2023-08-04 6 $38 $30 $32.428 $18.86 71.94%
2023-09-11 7 $38 $30 $32.714 $18.86 73.46%
2023-11-08 7 $38 $31 $33.142 $18.86 75.73%

The Trend in the Analyst Price Target


VRNA's average price target has moved up $2 over the prior 28 weeks.

Over the past 42 weeks, VRNA's average upside potential has been 64.25%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-02-07 5 33 26 30.000 22.32 34.41%
2023-03-23 6 35 28 31.142 19.85 56.89%
2023-06-07 6 38 30 32.428 20.69 56.73%
2023-08-04 6 38 30 32.428 19.93 62.71%
2023-09-01 7 38 30 32.714 19.40 68.63%

VRNA Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 7 0 0 0 0 7

The Trend in the Broker Recommendations


Over the past 16 months, VRNA's average broker recommendation rating improved by 0.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for VRNA as an investment opportunity.

  • VERONA PHARMA PLC's number of analysts covering the stock is greater than 603.27% of all US stocks.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, VERONA PHARMA PLC's variance in analysts' estimates is lower than -351.05% of them.
  • VRNA has a higher average analyst price target than 1647.83% of stocks in the small market cap category.
  • VRNA has a higher upside potential (average analyst target price relative to current price) than 772.99% of Pharmaceutical Products stocks.

Stocks similar to VERONA PHARMA PLC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are URGN, VBIV, and ATNF.

What is the outlook for VRNA? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!